{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:12:43Z","timestamp":1793506363885,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Basic Research Program of China","award":["2014CB931901"],"award-info":[{"award-number":["2014CB931901"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673022"],"award-info":[{"award-number":["81673022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373346"],"award-info":[{"award-number":["81373346"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Provincial Natural Science Foundation of China","doi-asserted-by":"publisher","award":["LY17H160013"],"award-info":[{"award-number":["LY17H160013"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Provincial Natural Science Foundation of China","doi-asserted-by":"publisher","award":["LY15H300001"],"award-info":[{"award-number":["LY15H300001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Funds for the Central Universities","award":["2017XZZX011-04"],"award-info":[{"award-number":["2017XZZX011-04"]}]},{"name":"Zhejiang Medical and Health Science and Technology Plan Project","award":["2016KYB109"],"award-info":[{"award-number":["2016KYB109"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ejpb.2019.02.009","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T02:48:11Z","timestamp":1550198891000},"page":"122-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment"],"prefix":"10.1016","volume":"137","author":[{"given":"Zhen-Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yi","family":"Huang-Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2019.02.009_b0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejpb.2019.02.009_b0010","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fonc.2016.00262","article-title":"The tumor microenvironment modulates choline and lipid metabolism","volume":"6","author":"Mori","year":"2016","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.ejpb.2019.02.009_b0015","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.ejpb.2019.02.009_b0020","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2217\/nnm-2017-0068","article-title":"Protease-activated nanomaterials for targeted cancer theranostics","volume":"12","author":"Chan","year":"2017","journal-title":"Nanomedicine (Lond)"},{"issue":"6230","key":"10.1016\/j.ejpb.2019.02.009_b0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2019.02.009_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.copbio.2016.02.007","article-title":"Impact of the physical microenvironment on tumor progression and metastasis","volume":"40","author":"Spill","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"issue":"2","key":"10.1016\/j.ejpb.2019.02.009_b0035","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev."},{"issue":"5930","key":"10.1016\/j.ejpb.2019.02.009_b0040","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander","year":"2009","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ejpb.2019.02.009_b0045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: a perfect storm for cancer progression","volume":"11","author":"Webb","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.ejpb.2019.02.009_b0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.ejpb.2019.02.009_b0055","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.addr.2012.01.002","article-title":"Enzyme-responsive nanoparticles for drug release and diagnostics","volume":"64","author":"de la Rica","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.ejpb.2019.02.009_b0060","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.ejmech.2007.12.021","article-title":"The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs","volume":"43","author":"Cheng","year":"2008","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejpb.2019.02.009_b0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/17425247.4.5.495","article-title":"Dendritic systems in drug delivery applications","volume":"4","author":"Jain","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"issue":"11","key":"10.1016\/j.ejpb.2019.02.009_b0070","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.2007.15.7438","article-title":"Monoclonal antibodies in cancer therapy: 25 years of progress","volume":"26","author":"Oldham","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ejpb.2019.02.009_b0075","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.addr.2008.04.012","article-title":"Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance","volume":"60","author":"Thurber","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"51","key":"10.1016\/j.ejpb.2019.02.009_b0080","doi-asserted-by":"crossref","first-page":"17867","DOI":"10.1073\/pnas.0408191101","article-title":"Tumor imaging by means of proteolytic activation of cell-penetrating peptides","volume":"101","author":"Jiang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ejpb.2019.02.009_b0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1039\/c2ib20135f","article-title":"Stimulus-responsive nanopreparations for tumor targeting","volume":"5","author":"Zhu","year":"2013","journal-title":"Integr. Biol. (Camb)"},{"issue":"1SI","key":"10.1016\/j.ejpb.2019.02.009_b0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbapap.2011.05.013","article-title":"Proteases in autophagy","volume":"1824","author":"Kaminskyy","year":"2012","journal-title":"Biochimica et Biophysica Acta-Proteins and Proteomics"},{"issue":"3","key":"10.1016\/j.ejpb.2019.02.009_b0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1039\/C4CC07563C","article-title":"MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery","volume":"51","author":"Chen","year":"2015","journal-title":"Chem. Commun. (Camb)"},{"issue":"104","key":"10.1016\/j.ejpb.2019.02.009_b0100","doi-asserted-by":"crossref","first-page":"85933","DOI":"10.1039\/C5RA18833D","article-title":"Multistage drug delivery system based on microenvironment-responsive dendrimer-gelatin nanoparticles for deep tumor penetration","volume":"5","author":"Hu","year":"2015","journal-title":"RSC Adv."},{"issue":"13","key":"10.1016\/j.ejpb.2019.02.009_b0105","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1016\/j.biomaterials.2014.01.060","article-title":"Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs","volume":"35","author":"Zhu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2019.02.009_b0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jconrel.2016.08.016","article-title":"Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer","volume":"239","author":"Grunwald","year":"2016","journal-title":"J. Control. Release"},{"issue":"31","key":"10.1016\/j.ejpb.2019.02.009_b0115","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1002\/adma.201501803","article-title":"Therapeutic enzyme-responsive nanoparticles for targeted delivery and accumulation in tumors","volume":"27","author":"Callmann","year":"2015","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.ejpb.2019.02.009_b0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/smll.201301456","article-title":"Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy","volume":"10","author":"Ansari","year":"2014","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2019.02.009_b0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1479-5876-11-192","article-title":"Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study","volume":"11","author":"Wang","year":"2013","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.ejpb.2019.02.009_b0130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<600::AID-IJC18>3.0.CO;2-C","article-title":"HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro","volume":"75","author":"Omelyanenko","year":"1998","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ejpb.2019.02.009_b0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejca.2003.07.001","article-title":"Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells","volume":"40","author":"David","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"47","key":"10.1016\/j.ejpb.2019.02.009_b0140","doi-asserted-by":"crossref","first-page":"15309","DOI":"10.1002\/chem.201404382","article-title":"Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles","volume":"20","author":"de la Torre","year":"2014","journal-title":"Chemistry"},{"issue":"3","key":"10.1016\/j.ejpb.2019.02.009_b0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2013.02.007","article-title":"Pancreatic cancer-associated Cathepsin E as a drug activator","volume":"167","author":"Abd-Elgaliel","year":"2013","journal-title":"J. Control. Release"},{"issue":"2735","key":"10.1016\/j.ejpb.2019.02.009_b0150","article-title":"Selective cancer targeting with prodrugs activated by histone deacetylases and a tumour-associated protease","volume":"4","author":"Ueki","year":"2013","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ejpb.2019.02.009_b0155","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/81351","article-title":"A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo","volume":"6","author":"DeFeo-Jones","year":"2000","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.ejpb.2019.02.009_b0160","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jnci\/95.13.990","article-title":"Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer","volume":"95","author":"Denmeade","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.ejpb.2019.02.009_b0165","first-page":"451","article-title":"A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo","volume":"1","author":"DeFeo-Jones","year":"2002","journal-title":"Mol. Cancer Ther."},{"issue":"17","key":"10.1016\/j.ejpb.2019.02.009_b0170","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/S0960-894X(02)00433-X","article-title":"A 5-fluorodeoxyuridine prodrug as targeted therapy for prostate cancer","volume":"12","author":"Mhaka","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"14","key":"10.1016\/j.ejpb.2019.02.009_b0175","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1016\/j.bmc.2007.04.029","article-title":"Modulating paclitaxel bioavailability for targeting prostate cancer","volume":"15","author":"Kumar","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejpb.2019.02.009_b0180","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1021\/jm00359a004","article-title":"Plasmin-activated prodrugs for cancer chemotherapy. 2. Synthesis and biological activity of peptidyl derivatives of doxorubicin","volume":"26","author":"Chakravarty","year":"1983","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejpb.2019.02.009_b0185","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1021\/jm300714p","article-title":"Synthesis and biological characterization of protease-activated prodrugs of doxazolidine","volume":"55","author":"Barthel","year":"2012","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejpb.2019.02.009_b0190","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.bmc.2010.04.070","article-title":"Controlled release of PEG chain from gold nanorods: targeted delivery to tumor","volume":"18","author":"Niidome","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"86","key":"10.1016\/j.ejpb.2019.02.009_b0195","doi-asserted-by":"crossref","first-page":"45961","DOI":"10.1039\/C4RA07815B","article-title":"Dual enzyme responsive and targeted nanocapsules for intracellular delivery of anticancer agents","volume":"4","author":"Radhakrishnan","year":"2014","journal-title":"RSC Adv."},{"issue":"12","key":"10.1016\/j.ejpb.2019.02.009_b0200","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1039\/C4SM02896A","article-title":"Enzyme-responsive protein\/polysaccharide supramolecular nanoparticles","volume":"11","author":"Hou","year":"2015","journal-title":"Soft Matter"},{"issue":"1","key":"10.1016\/j.ejpb.2019.02.009_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbamem.2005.02.012","article-title":"Synthesis and membrane behavior of a new class of unnatural phospholipid analogs useful as phospholipase A2 degradable liposomal drug carriers","volume":"1669","author":"Andresen","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.ejpb.2019.02.009_b0210","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/bm8013022","article-title":"Dextrin-phospholipase A2: synthesis and evaluation as a bioresponsive anticancer conjugate","volume":"10","author":"Ferguson","year":"2009","journal-title":"Biomacromolecules"},{"issue":"11","key":"10.1016\/j.ejpb.2019.02.009_b0215","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1021\/nn101499d","article-title":"Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with \u201cSaccharides\u201d","volume":"4","author":"Bernardos","year":"2010","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.ejpb.2019.02.009_b0220","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.leukres.2013.04.026","article-title":"A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts","volume":"37","author":"Clarhaut","year":"2013","journal-title":"Leuk. Res."},{"issue":"38","key":"10.1016\/j.ejpb.2019.02.009_b0225","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.1021\/ja407514z","article-title":"Enzyme sensitive synthetic polymer micelles based on the azobenzene motif","volume":"135","author":"Rao","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"19","key":"10.1016\/j.ejpb.2019.02.009_b0230","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.biomaterials.2013.02.070","article-title":"Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells","volume":"34","author":"Medina","year":"2013","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ejpb.2019.02.009_b0235","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/ja511843w","article-title":"Nano-gold corking and enzymatic uncorking of carbon nanotube cups","volume":"137","author":"Zhao","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.ejpb.2019.02.009_b0240","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Database issue","key":"10.1016\/j.ejpb.2019.02.009_b0245","doi-asserted-by":"crossref","first-page":"D503","DOI":"10.1093\/nar\/gkt953","article-title":"MEROPS: the database of proteolytic enzymes, their substrates and inhibitors","volume":"42","author":"Rawlings","year":"2014","journal-title":"Nucl. Acids Res."},{"issue":"11","key":"10.1016\/j.ejpb.2019.02.009_b0250","doi-asserted-by":"crossref","first-page":"F1351","DOI":"10.1152\/ajprenal.00037.2012","article-title":"Matrix metalloproteinases in kidney homeostasis and diseases","volume":"302","author":"Tan","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejpb.2019.02.009_b0255","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.matbio.2015.01.019","article-title":"Moving targets: Emerging roles for MMPs in cancer progression and metastasis","volume":"44\u201346","author":"Shay","year":"2015","journal-title":"Matrix Biol."},{"issue":"31","key":"10.1016\/j.ejpb.2019.02.009_b0260","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2009.23.5556","article-title":"Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer","volume":"27","author":"Roy","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ejpb.2019.02.009_b0265","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1021\/nn300524f","article-title":"Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting","volume":"6","author":"Zhu","year":"2012","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.ejpb.2019.02.009_b0270","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/26\/14\/145102","article-title":"Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo","volume":"26","author":"Liu","year":"2015","journal-title":"Nanotechnology"},{"issue":"45","key":"10.1016\/j.ejpb.2019.02.009_b0275","doi-asserted-by":"crossref","first-page":"39209","DOI":"10.1021\/acsami.7b12918","article-title":"Cell-permeable, MMP-2 activatable, nickel ferrite and his-tagged fusion protein self-assembled fluorescent nanoprobe for tumor magnetic-targeting and imaging","volume":"9","author":"Sun","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.02.009_b0280","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2009.11.023","article-title":"Anticancer activity of PEGylated matrix metalloproteinase cleavable peptide-conjugated adriamycin against malignant glioma cells","volume":"387","author":"Lim","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2019.02.009_b0285","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.actbio.2011.02.005","article-title":"Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery","volume":"7","author":"Garripelli","year":"2011","journal-title":"Acta Biomater."},{"issue":"24","key":"10.1016\/j.ejpb.2019.02.009_b0290","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1002\/smll.201400654","article-title":"Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging","volume":"10","author":"Cheng","year":"2014","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2019.02.009_b0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2017.11.003","article-title":"Doxorubicin encapsulated clicked gold nanoparticle clusters exhibiting tumor-specific disassembly for enhanced tumor localization and computerized tomographic imaging","volume":"269","author":"Mao","year":"2018","journal-title":"J. Control. Release"},{"issue":"49","key":"10.1016\/j.ejpb.2019.02.009_b0300","doi-asserted-by":"crossref","first-page":"42459","DOI":"10.1021\/acsami.7b10098","article-title":"MMP-2-sensitive HA end-conjugated poly(amidoamine) dendrimers via click reaction to enhance drug penetration into solid tumor","volume":"9","author":"Han","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"10.1016\/j.ejpb.2019.02.009_b0305","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc1949","article-title":"Cysteine cathepsins: multifunctional enzymes in cancer","volume":"6","author":"Mohamed","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.ejpb.2019.02.009_b0310","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.bbagen.2014.03.017","article-title":"Cysteine cathepsins and extracellular matrix degradation","volume":"1840","author":"Fonovic","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ejpb.2019.02.009_b0315","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0167-4889(93)90109-3","article-title":"Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes","volume":"1178","author":"Kobayashi","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.ejpb.2019.02.009_b0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd4519","article-title":"Principles in the design of ligand-targeted cancer therapeutics and imaging agents","volume":"14","author":"Srinivasarao","year":"2015","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"17","key":"10.1016\/j.ejpb.2019.02.009_b0325","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1021\/acsami.5b00752","article-title":"Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles","volume":"7","author":"Cheng","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"8SI","key":"10.1016\/j.ejpb.2019.02.009_b0330","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/adhm.201300613","article-title":"Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells","volume":"3","author":"Li","year":"2014","journal-title":"Adv. Healthcare Mater."},{"issue":"50","key":"10.1016\/j.ejpb.2019.02.009_b0335","doi-asserted-by":"crossref","first-page":"12486","DOI":"10.1002\/anie.201206416","article-title":"Enzyme-responsive controlled release of covalently bound prodrug from functional mesoporous silica nanospheres","volume":"51","author":"Popat","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.ejpb.2019.02.009_b0340","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1200\/JCO.1998.16.3.1013","article-title":"Prognostic significance of cathepsins B and L in primary human breast cancer","volume":"16","author":"Foekens","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejpb.2019.02.009_b0345","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/cmdc.200700159","article-title":"Prodrug strategies in anticancer chemotherapy","volume":"3","author":"Kratz","year":"2008","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.ejpb.2019.02.009_b0350","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1021\/bc010063m","article-title":"Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect","volume":"13","author":"Kovar","year":"2002","journal-title":"Bioconjug. Chem."},{"issue":"1\u20133","key":"10.1016\/j.ejpb.2019.02.009_b0355","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-3659(01)00495-3","article-title":"Design of novel bioconjugates for targeted drug delivery","volume":"78","author":"Lu","year":"2002","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ejpb.2019.02.009_b0360","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1021\/acs.bioconjchem.6b00099","article-title":"Design, synthesis, and biological evaluation of new cathepsin B-sensitive Camptothecin nanoparticles equipped with a novel multifuctional linker","volume":"27","author":"Zhang","year":"2016","journal-title":"Bioconjug. Chem."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.02.009_b0365","first-page":"183","article-title":"Molecular cloning of cDNA coding for human preprourokinase","volume":"36","author":"Nagai","year":"1985","journal-title":"Gene"},{"issue":"9","key":"10.1016\/j.ejpb.2019.02.009_b0370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0167-5699(97)01121-3","article-title":"uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?","volume":"18","author":"Blasi","year":"1997","journal-title":"Immunol. Today"},{"issue":"6","key":"10.1016\/j.ejpb.2019.02.009_b0375","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.7150\/thno.18125","article-title":"Tumor penetrating theranostic nanoparticles for enhancement of targeted and image-guided drug delivery into peritoneal tumors following intraperitoneal delivery","volume":"7","author":"Gao","year":"2017","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.ejpb.2019.02.009_b0380","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.2003.02.083","article-title":"Biology of prostate-specific antigen","volume":"21","author":"Balk","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ejpb.2019.02.009_b0385","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men","volume":"151","author":"Catalona","year":"1994","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.ejpb.2019.02.009_b0390","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.3390\/ijms140611034","article-title":"Current status of biomarkers for prostate cancer","volume":"14","author":"Velonas","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2019.02.009_b0395","first-page":"19","article-title":"Families of serine peptidases","volume":"244","author":"Rawlings","year":"1994","journal-title":"MethodsEnzymol"},{"issue":"6SI","key":"10.1016\/j.ejpb.2019.02.009_b0400","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.biochi.2010.03.019","article-title":"Emerging roles for phospholipase A(2) enzymes in cancer","volume":"92","author":"Scott","year":"2010","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.ejpb.2019.02.009_b0405","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1023\/A:1024088922957","article-title":"Phospholipase C-gamma1 in tumor progression","volume":"20","author":"Wells","year":"2003","journal-title":"Clin. Exp. Metastasis"},{"issue":"8","key":"10.1016\/j.ejpb.2019.02.009_b0410","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1096\/fj.12-207597","article-title":"Elevated and secreted phospholipase A(2) activities as new potential therapeutic targets in human epithelial ovarian cancer","volume":"26","author":"Cai","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.ejpb.2019.02.009_b0415","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.biochem.76.062405.154007","article-title":"Biochemistry and physiology of mammalian secreted phospholipases A2","volume":"77","author":"Lambeau","year":"2008","journal-title":"Annu. Rev. Biochem."},{"issue":"6","key":"10.1016\/j.ejpb.2019.02.009_b0420","article-title":"Decline in topsoil microbial quotient, fungal abundance and C utilization efficiency of rice paddies under heavy metal pollution across South China","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejpb.2019.02.009_b0425","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1039\/c2ib20108a","article-title":"Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer","volume":"5","author":"Mock","year":"2013","journal-title":"Integr. Biol. (Camb)"},{"issue":"46","key":"10.1016\/j.ejpb.2019.02.009_b0430","doi-asserted-by":"crossref","first-page":"16614","DOI":"10.1021\/ja9061085","article-title":"Enzyme responsive nanocontainers with cyclodextrin gatekeepers and synergistic effects in release of guests","volume":"131","author":"Park","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2019.02.009_b0435","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biomaterials.2017.03.012","article-title":"Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis","volume":"128","author":"Pawlowski","year":"2017","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.ejpb.2019.02.009_b0440","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0959-440X(00)00253-0","article-title":"Glycoside hydrolases and glycosyltransferases: families and functional modules","volume":"11","author":"Bourne","year":"2001","journal-title":"Curr. Opin. Struct. Biol"},{"issue":"1","key":"10.1016\/j.ejpb.2019.02.009_b0445","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01600149","article-title":"Immunohistochemical, ultrastructural and biochemical studies of an amylase-producing breast carcinoma","volume":"419","author":"Inaji","year":"1991","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"2","key":"10.1016\/j.ejpb.2019.02.009_b0450","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0016-5085(88)90447-7","article-title":"A unique case of breast carcinoma producing pancreatic-type isoamylase","volume":"94","author":"Weitzel","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejpb.2019.02.009_b0455","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2017.08.008","article-title":"Development and evaluation of beta-galactosidase-sensitive antibody-drug conjugates","volume":"142","author":"Kolodych","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejpb.2019.02.009_b0460","doi-asserted-by":"crossref","unstructured":"E.J. toone, Advances in Enzymology and Related Areas of Molecular Biology, Vol 75: Protein Evolution, 2007.","DOI":"10.1002\/9780471224464"},{"issue":"2","key":"10.1016\/j.ejpb.2019.02.009_b0465","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-2010-1375","article-title":"Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration","volume":"20","author":"Butterfield","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.ejpb.2019.02.009_b0470","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11095-010-0096-8","article-title":"Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis","volume":"27","author":"Kundu","year":"2010","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2019.02.009_b0475","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0168-3659(01)00405-9","article-title":"Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin","volume":"75","author":"Sakuma","year":"2001","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ejpb.2019.02.009_b0480","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0891-5849(94)00198-S","article-title":"Superoxide and hydrogen peroxide in relation to mammalian cell proliferation","volume":"18","author":"Burdon","year":"1995","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.ejpb.2019.02.009_b0485","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/10408360500523878","article-title":"Glutathione in cancer biology and therapy","volume":"43","author":"Estrela","year":"2006","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2019.02.009_b0490","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2013.01.001","article-title":"Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release","volume":"169","author":"Chen","year":"2013","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejpb.2019.02.009_b0495","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1039\/C0NR00779J","article-title":"Oxidative biodegradation of single- and multi-walled carbon nanotubes","volume":"3","author":"Russier","year":"2011","journal-title":"Nanoscale"},{"issue":"11","key":"10.1016\/j.ejpb.2019.02.009_b0500","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1021\/nl802315h","article-title":"Biodegradation of single-walled carbon nanotubes through enzymatic catalysis","volume":"8","author":"Allen","year":"2008","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2019.02.009_b0505","first-page":"129","article-title":"Advances in clinical research of matrix metalloproteinase inhibitors as anticancer agents","volume":"02","author":"HanYanzhen","year":"2018","journal-title":"Prog. Pharm. Sci."},{"issue":"Spec Feature","key":"10.1016\/j.ejpb.2019.02.009_b0510","first-page":"102","article-title":"Ninlaro (Ixazomib): first oral proteasome inhibitor approved for the treatment of patients with relapsed or refractory multiple myeloma","volume":"9","author":"Raedler","year":"2016","journal-title":"Am. Health Drug Benefits"},{"issue":"4","key":"10.1016\/j.ejpb.2019.02.009_b0515","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jtcvs.2014.11.088","article-title":"Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans","volume":"149","author":"Krenn","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"12","key":"10.1016\/j.ejpb.2019.02.009_b0520","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1200\/JCO.2005.04.044","article-title":"Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18","volume":"23","author":"Leighl","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ejpb.2019.02.009_b0525","first-page":"1069","article-title":"Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression","volume":"40","author":"Cho","year":"2007","journal-title":"J. Biochem. Mol. Biol."},{"issue":"12","key":"10.1016\/j.ejpb.2019.02.009_b0530","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.bbagen.2012.07.013","article-title":"Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid","volume":"1820","author":"Dedes","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.ejpb.2019.02.009_b0535","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaad.2016.01.019","article-title":"Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: a randomized, open-label trial","volume":"74","author":"Deplanque","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"issue":"12","key":"10.1016\/j.ejpb.2019.02.009_b0540","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/jnci\/djq179","article-title":"Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial","volume":"102","author":"Lu","year":"2010","journal-title":"J. Natl Cancer Inst."},{"issue":"4","key":"10.1016\/j.ejpb.2019.02.009_b0545","first-page":"1101","article-title":"Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors","volume":"26","author":"Kousidou","year":"2005","journal-title":"Int. J. Oncol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118312530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118312530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T16:22:56Z","timestamp":1720974176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118312530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":109,"alternative-id":["S0939641118312530"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.02.009","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}